1. 1) Klingmann V, Spomer N, Lerch C, Stoltenberg I, Frömke C, Bosse HM, Breitkreutz J, Meissner T. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children. J. Pediatr., 163, 1728–1732.e1 (2013).
2. 2) Klingmann V, Seitz A, Meissner T, Breitkreutz J, Moeltner A, Bosse HM. Acceptability of uncoated mini-tablets in neonates—a randomized controlled trial. J. Pediatr., 167, 893–896.e2 (2015).
3. 3) van Riet-Nales DA, de Neef BJ, Schobben AF, Ferreira JA, Egberts TC, Rademaker CM. Acceptability of different oral formulations in infants and preschool children. Arch. Dis. Child., 98, 725–731 (2013).
4. 4) McCrindle BW, O’Neill MB, Cullen-Dean G, Helden E. Acceptability and compliance with two forms of cholestyramine in the treatment of hypercholesterolemia in children: a randomized, crossover trial. J. Pediatr., 130, 266–273 (1997).
5. 5) European Medicines Agency. “Reflection paper: Formulations of choice for the paediatric population.”: ‹https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-formulations-choice-paediatric-population_en.pdf›, accessed 5 May, 2020.